Skip to main content

Animations

MJFF Publications

7941 - 7950 of 8808 Results
Title
Year
  • Year
  • 2020
  • 2023
  • 2019
  • 2023
  • 2019
  • 2013
  • 2025
  • 2019
  • 2019
  • 2016
  • Summary Details
    OPEN
    Title: Accurate MS-based Rab10 Phosphorylation Stoichiometry Determination as Readout for LRRK2 Activity in Parkinson's Disease
    Journal Name: Molecular & Cellular Proteomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1074/mcp.ra120.002055
    Citation Count: 58
  • Summary Details
    OPEN
    Title: PTPA variants and the risk for Parkinson’s disease in diverse ancestry populations
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awad247
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Screening of the glucocerebrosidase (GBA) gene in South Africans of African ancestry with Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.12.011
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation
    Journal Name: Aging Cell
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/acel.13814
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Defining α-synuclein species responsible for Parkinson’s disease phenotypes in mice
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1074/jbc.ra119.007743
    Citation Count: 114
  • Summary Details
    RESTRICTED
    Title: Improvement of freezing of gait with amantadine in a patient with oculopharyngeal muscular dystrophy and parkinsonism
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.02.016
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Altered network efficiency in isolated REM sleep behavior disorder: A multicentric study
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.70574
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Altered dynamics of visual contextual interactions in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-019-0085-5
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30140-1
    Citation Count: 88
  • Summary Details
    RESTRICTED
    Title: A Phase 2A Trial of the Novel mGluR5‐Negative Allosteric Modulator Dipraglurant for Levodopa‐Induced Dyskinesia in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26659
    Citation Count: 130
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.